Skip to main content

Sanofi to acquire Synthorx for $2.5 billion

The French pharmaceutical company said it plans to take control of all outstanding shares of Synthorx for $68 per share in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.